Literature DB >> 25183319

Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder.

Carolina Rosadas1, Ana C P Vicente, Louise Zanella, Mauro J Cabral-Castro, José M Peralta, Marzia Puccioni-Sohler.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25183319     DOI: 10.1007/s13365-014-0280-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  14 in total

1.  Validation of a quantitative real-time PCR assay for HTLV-1 proviral load in peripheral blood mononuclear cells.

Authors:  Carolina Rosadas; Mauro Jorge Cabral-Castro; Ana Carolina Paulo Vicente; José Mauro Peralta; Marzia Puccioni-Sohler
Journal:  J Virol Methods       Date:  2013-08-01       Impact factor: 2.014

2.  Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.

Authors:  Marcus Tulius T Silva; Ramza Cabral Harab; Ana Cláudia Leite; Doris Schor; Abelardo Araújo; Maria José Andrada-Serpa
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

3.  Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index.

Authors:  M Puccioni-Sohler; M Rios; S M Carvalho; R R Gonçalves; C Oliveira; R B Correa; S Novis; M S de Oliveira; C Bianco
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

4.  Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.

Authors:  T J Lehky; N Flerlage; D Katz; S Houff; W H Hall; K Ishii; C Monken; S Dhib-Jalbut; H F McFarland; S Jacobson
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

5.  Spastic ataxia associated with human T-cell lymphotropic virus type II infection.

Authors:  W J Harrington; W Sheremata; B Hjelle; D K Dube; P Bradshaw; S K Foung; S Snodgrass; G Toedter; L Cabral; B Poiesz
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

6.  Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  S Jacobson; T Lehky; M Nishimura; S Robinson; D E McFarlin; S Dhib-Jalbut
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

7.  Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.

Authors:  Helena Kaminami Morimoto; Arilson Akira Morimoto; Edna Maria Vissoci Reiche; Luiz Toshio Ueda; Tiemi Matsuo; Fernando Vissoci Reiche; Adele Caterino-de-Araujo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2007 Jul-Aug       Impact factor: 1.846

8.  Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Authors:  Edward L Murphy; Tzong-Hae Lee; Daniel Chafets; Catharie C Nass; Baoguang Wang; Katharine Loughlin; Donna Smith
Journal:  J Infect Dis       Date:  2004-07-06       Impact factor: 5.226

Review 9.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

10.  Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients.

Authors:  Masoomeh Sofian; Arezoo Aghakhani; Ali Asghar Farazi; Mohammad Banifazl; Ali Eslamifar; Niloofar Rashidi; Akbar Khadem Sadegh; Amitis Ramezani
Journal:  Hepat Mon       Date:  2012-12-29       Impact factor: 0.660

View more
  2 in total

1.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

Review 2.  Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.

Authors:  Carlos Brites; Maria Fernanda Grassi; Juarez Antônio Simões Quaresma; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Braz J Infect Dis       Date:  2021-07-10       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.